Raymond James Financial Inc. Invests $85,000 in Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Raymond James Financial Inc. bought a new position in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 44,748 shares of the biopharmaceutical company’s stock, valued at approximately $85,000. Several other hedge funds also recently added to or […]
Raymond James Financial Inc. bought a new position in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 44,748 shares of the biopharmaceutical company’s stock, valued at approximately $85,000. Several other hedge funds also recently added to or […]